María Fernanda García-Aguilera, Nayely García-Méndez, Glenn Hernández, Borja M Fernández-Félix, Harold Alexander-León, Yunqi Yu-Liu, Josue Rivadeneira, Luis Fuenmayor-González, Cristopher Isaac Peña Robayo, Fernanda Villalba, Eduardo Andrés Aragundi Palacios, Emérita Eugenia Basantes Borja, Henry Caballero Narvaez, Isabel Morales Alcocer, Eduardo Velazco, Georgina Muñoz, Juan Pablo Holguín-Carvajal, Tamara Otzen Hernández, Carlos Manterola
{"title":"重症监护病房中癌症伴脓毒症患者死亡率的预后因素评估:系统评价方案。","authors":"María Fernanda García-Aguilera, Nayely García-Méndez, Glenn Hernández, Borja M Fernández-Félix, Harold Alexander-León, Yunqi Yu-Liu, Josue Rivadeneira, Luis Fuenmayor-González, Cristopher Isaac Peña Robayo, Fernanda Villalba, Eduardo Andrés Aragundi Palacios, Emérita Eugenia Basantes Borja, Henry Caballero Narvaez, Isabel Morales Alcocer, Eduardo Velazco, Georgina Muñoz, Juan Pablo Holguín-Carvajal, Tamara Otzen Hernández, Carlos Manterola","doi":"10.62675/2965-2774.20250283","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>This systematic review outlines a comprehensive approach to identify and analyze prognostic factors associated with mortality in adult cancer patients with sepsis in the intensive care unit. The review will focus on all-cause 28-day mortality, and where not available, we will use 30-day, intensive care unit, or in-hospital mortality.</p><p><strong>Methods and analysis: </strong>We present a protocol for the systematic review of prognostic factors for mortality in adult cancer patients with sepsis managed in the intensive care unit. Our primary outcome is 28-day mortality, and where not available, we will use 30-day, intensive care unit, or in-hospital mortality. The secondary outcome is the global mortality incidence. Studies on the basis of the population (sepsis and neoplasms), prognostic study methods and outcome of interest (mortality) will be included. We will search the following databases: Medline, PubMed, EMBASE, SCOPUS, Web of Science, and Bireme-BVS, until April 5, 2024. The risk of bias will be assessed using the QUIPS tool. A meta-analysis will be conducted where possible to generate pooled estimates for identified prognostic factors. Two authors will independently assess the risk of bias in each study using the Quality in Prognostic Studies tool. The GRADE approach will be employed to evaluate the overall quality of evidence and the strength of the recommendations. Findings will be disseminated through publication in a peer-reviewed journal. This review aims to provide clinicians with valuable insights into factors influencing mortality risk in this high-risk population, ultimately informing clinical decision-making and improving patient outcomes.</p><p><strong>Ethics and socialization: </strong>The results of this review will be published in a peer-reviewed scientific journal. Does not require ethical approval.</p>","PeriodicalId":72721,"journal":{"name":"Critical care science","volume":"37 ","pages":"e20250283"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12040416/pdf/","citationCount":"0","resultStr":"{\"title\":\"Evaluation of prognostic factors for mortality in cancer patients with sepsis in the intensive care unit: systematic review protocol.\",\"authors\":\"María Fernanda García-Aguilera, Nayely García-Méndez, Glenn Hernández, Borja M Fernández-Félix, Harold Alexander-León, Yunqi Yu-Liu, Josue Rivadeneira, Luis Fuenmayor-González, Cristopher Isaac Peña Robayo, Fernanda Villalba, Eduardo Andrés Aragundi Palacios, Emérita Eugenia Basantes Borja, Henry Caballero Narvaez, Isabel Morales Alcocer, Eduardo Velazco, Georgina Muñoz, Juan Pablo Holguín-Carvajal, Tamara Otzen Hernández, Carlos Manterola\",\"doi\":\"10.62675/2965-2774.20250283\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>This systematic review outlines a comprehensive approach to identify and analyze prognostic factors associated with mortality in adult cancer patients with sepsis in the intensive care unit. The review will focus on all-cause 28-day mortality, and where not available, we will use 30-day, intensive care unit, or in-hospital mortality.</p><p><strong>Methods and analysis: </strong>We present a protocol for the systematic review of prognostic factors for mortality in adult cancer patients with sepsis managed in the intensive care unit. Our primary outcome is 28-day mortality, and where not available, we will use 30-day, intensive care unit, or in-hospital mortality. The secondary outcome is the global mortality incidence. Studies on the basis of the population (sepsis and neoplasms), prognostic study methods and outcome of interest (mortality) will be included. We will search the following databases: Medline, PubMed, EMBASE, SCOPUS, Web of Science, and Bireme-BVS, until April 5, 2024. The risk of bias will be assessed using the QUIPS tool. A meta-analysis will be conducted where possible to generate pooled estimates for identified prognostic factors. Two authors will independently assess the risk of bias in each study using the Quality in Prognostic Studies tool. The GRADE approach will be employed to evaluate the overall quality of evidence and the strength of the recommendations. Findings will be disseminated through publication in a peer-reviewed journal. This review aims to provide clinicians with valuable insights into factors influencing mortality risk in this high-risk population, ultimately informing clinical decision-making and improving patient outcomes.</p><p><strong>Ethics and socialization: </strong>The results of this review will be published in a peer-reviewed scientific journal. Does not require ethical approval.</p>\",\"PeriodicalId\":72721,\"journal\":{\"name\":\"Critical care science\",\"volume\":\"37 \",\"pages\":\"e20250283\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-05-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12040416/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Critical care science\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.62675/2965-2774.20250283\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Critical care science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.62675/2965-2774.20250283","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
简介:本系统综述概述了一种识别和分析重症监护病房成年癌症脓毒症患者死亡率相关预后因素的综合方法。审查将侧重于28天全因死亡率,如果没有,我们将使用30天、重症监护病房或住院死亡率。方法和分析:我们提出了一项方案,对重症监护病房管理的成年癌症脓毒症患者死亡率的预后因素进行系统回顾。我们的主要终点是28天死亡率,如果没有,我们将使用30天、重症监护病房或住院死亡率。次要结果是全球死亡率。以人群为基础的研究(败血症和肿瘤)、预后研究方法和感兴趣的结果(死亡率)将被包括在内。我们将搜索以下数据库:Medline, PubMed, EMBASE, SCOPUS, Web of Science和Bireme-BVS,直到2024年4月5日。将使用QUIPS工具评估偏倚风险。在可能的情况下,将进行荟萃分析,对已确定的预后因素进行汇总估计。两位作者将使用预后研究质量工具独立评估每项研究的偏倚风险。GRADE方法将用于评估证据的整体质量和建议的强度。研究结果将在同行评议的期刊上发表。本综述旨在为临床医生提供有价值的见解,了解影响这一高危人群死亡风险的因素,最终为临床决策提供信息并改善患者预后。伦理与社会化:本综述的结果将发表在同行评议的科学期刊上。不需要伦理批准。
Evaluation of prognostic factors for mortality in cancer patients with sepsis in the intensive care unit: systematic review protocol.
Introduction: This systematic review outlines a comprehensive approach to identify and analyze prognostic factors associated with mortality in adult cancer patients with sepsis in the intensive care unit. The review will focus on all-cause 28-day mortality, and where not available, we will use 30-day, intensive care unit, or in-hospital mortality.
Methods and analysis: We present a protocol for the systematic review of prognostic factors for mortality in adult cancer patients with sepsis managed in the intensive care unit. Our primary outcome is 28-day mortality, and where not available, we will use 30-day, intensive care unit, or in-hospital mortality. The secondary outcome is the global mortality incidence. Studies on the basis of the population (sepsis and neoplasms), prognostic study methods and outcome of interest (mortality) will be included. We will search the following databases: Medline, PubMed, EMBASE, SCOPUS, Web of Science, and Bireme-BVS, until April 5, 2024. The risk of bias will be assessed using the QUIPS tool. A meta-analysis will be conducted where possible to generate pooled estimates for identified prognostic factors. Two authors will independently assess the risk of bias in each study using the Quality in Prognostic Studies tool. The GRADE approach will be employed to evaluate the overall quality of evidence and the strength of the recommendations. Findings will be disseminated through publication in a peer-reviewed journal. This review aims to provide clinicians with valuable insights into factors influencing mortality risk in this high-risk population, ultimately informing clinical decision-making and improving patient outcomes.
Ethics and socialization: The results of this review will be published in a peer-reviewed scientific journal. Does not require ethical approval.